ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned

October 31, 1986

ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief.

January 18, 2002

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

Research Teams Win Honors For Cancer Immunotherapy Work

October 15, 2010

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010